133 related articles for article (PubMed ID: 11885975)
1. Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat.
Yamaguchi Y; Higashi M; Matsuno T; Kawashima S
Jpn J Pharmacol; 2001 Nov; 87(3):240-4. PubMed ID: 11885975
[TBL] [Abstract][Full Text] [Related]
2. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
4. Antiamnesic effects of azaindolizinone derivative ZSET845 on impaired learning and decreased ChAT activity induced by amyloid-beta 25-35 in the rat.
Yamaguchi Y; Matsuno T; Kawashima S
Brain Res; 2002 Aug; 945(2):259-65. PubMed ID: 12126888
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
[TBL] [Abstract][Full Text] [Related]
7. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M
Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A, a novel promising acetylcholinesterase inhibitor.
Cheng DH; Ren H; Tang XC
Neuroreport; 1996 Dec; 8(1):97-101. PubMed ID: 9051760
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
Cheng DH; Tang XC
Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220
[TBL] [Abstract][Full Text] [Related]
10. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.
Wang T; Tang XC
Eur J Pharmacol; 1998 May; 349(2-3):137-42. PubMed ID: 9671090
[TBL] [Abstract][Full Text] [Related]
11. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Saxena G; Singh SP; Agrawal R; Nath C
Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183
[TBL] [Abstract][Full Text] [Related]
12. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
Masuoka T; Kamei C
Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304
[TBL] [Abstract][Full Text] [Related]
13. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
[TBL] [Abstract][Full Text] [Related]
14. Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.
Lindner MD; Hogan JB; Hodges DB; Orie AF; Chen P; Corsa JA; Leet JE; Gillman KW; Rose GM; Jones KM; Gribkoff VK
Psychopharmacology (Berl); 2006 Nov; 188(4):629-40. PubMed ID: 17004085
[TBL] [Abstract][Full Text] [Related]
15. Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147.
Chen Z; Xu AJ; Li R; Wei EQ
Acta Pharmacol Sin; 2002 Apr; 23(4):355-60. PubMed ID: 11931694
[TBL] [Abstract][Full Text] [Related]
16. The effects of novel 7-MEOTA-donepezil like hybrids and N-alkylated tacrine analogues in the treatment of quinuclidinyl benzilate-induced behavioural deficits in rats performing the multiple T-maze test.
Misik J; Korabecny J; Nepovimova E; Cabelova P; Kassa J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):547-53. PubMed ID: 25690521
[TBL] [Abstract][Full Text] [Related]
17. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
Sonkusare S; Srinivasan K; Kaul C; Ramarao P
Life Sci; 2005 May; 77(1):1-14. PubMed ID: 15848214
[TBL] [Abstract][Full Text] [Related]
18. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.
Egawa T; Mishima K; Matsumoto Y; Iwasaki K; Iwasaki K; Fujiwara M
Jpn J Pharmacol; 1997 Nov; 75(3):275-81. PubMed ID: 9434259
[TBL] [Abstract][Full Text] [Related]
19. Effect of rivastigmine on scopolamine-induced memory impairment in rats.
Bejar C; Wang RH; Weinstock M
Eur J Pharmacol; 1999 Nov; 383(3):231-40. PubMed ID: 10594314
[TBL] [Abstract][Full Text] [Related]
20. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.
Yamaguchi Y; Kawashima S
Eur J Pharmacol; 2001 Feb; 412(3):265-72. PubMed ID: 11166290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
